R Benini
Overview
Explore the profile of R Benini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benini R, Prado Nunes P, Orsatti C, Barcelos L, Orsatti F
J Sports Med Phys Fitness
. 2015 Apr;
55(4):337-44.
PMID: 25853878
Aim: Sex differences in exercise responses have implications for understanding sex-specific adaptations to exercise for performance and health. The purpose of this study was to verify the acute effects of...
2.
Kadalayil L, Benini R, Pallan L, OBeirne J, Marelli L, Yu D, et al.
Ann Oncol
. 2013 Jul;
24(10):2565-2570.
PMID: 23857958
Background: The prognosis for patients with hepatocellular cancer (HCC) undergoing transarterial therapy (TACE/TAE) is variable. Methods: We carried out Cox regression analysis of prognostic factors using a training dataset of...
3.
Benini R, DAntuono M, Pralong E, Avoli M
Neuroscience
. 2003 Jul;
120(1):75-84.
PMID: 12849742
We used field potential and intracellular recordings in rat brain slices that included the hippocampus, a portion of the basolateral/lateral nuclei of the amygdala (BLA) and the entorhinal cortex (EC)....
4.
Ruggenenti P, Pagano E, Tammuzzo L, Benini R, Garattini L, Remuzzi G
Kidney Int
. 2001 Jan;
59(1):286-94.
PMID: 11135082
Background: Our objectives were to predict the long-term cost and efficacy of the angiotensin-converting enzyme, ramipril, in patients with nondiabetic chronic nephropathies. Methods: The time to end-stage renal disease (ESRD)...
5.
Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G
Am J Kidney Dis
. 2000 Jun;
35(6):1155-65.
PMID: 10845831
The Ramipril Efficacy in Nephropathy (REIN) study found that angiotensin-converting enzyme (ACE) inhibitors effectively decreased proteinuria, glomerular filtration rate (GFR) decline (DeltaGFR), and incidence of end-stage renal disease (ESRD) in...
6.
Perna A, Ruggenenti P, Testa A, Spoto B, Benini R, Misefari V, et al.
Kidney Int
. 2000 Jan;
57(1):274-81.
PMID: 10620209
Unlabelled: ACE genotype and ACE induced renoprotection in chronic proteinuric nephropathies. Background: Whether angiotensin-converting enzyme (ACE) gene polymorphism affects disease progression and response to ACE inhibitor therapy in nondiabetic proteinuric...
7.
Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, MAGGIORE Q, et al.
J Am Soc Nephrol
. 1999 May;
10(5):997-1006.
PMID: 10232685
The Ramipril Efficacy in Nephropathy Core and Follow-Up Study found that > or =36 mo of continued ramipril therapy decreased substantially the risk of end-stage renal failure (ESRF) in patients...
8.
Ruggenenti P, Perna A, Benini R, Remuzzi G
J Am Soc Nephrol
. 1998 Nov;
9(11):2096-101.
PMID: 9808096
Dihydropyridine-type calcium channel blockers (dihydropyridine CCB) adversely affect renal function in diabetes. The effects of dihydropyridine CCB on 24-h urinary protein excretion rate and GFR decline (deltaGFR) were prospectively evaluated...
9.
Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G
Lancet
. 1998 Oct;
352(9136):1252-6.
PMID: 9788454
Background: The Ramipril Efficacy In Nephropathy (REIN) study found that in patients with chronic nephropathies and proteinuria of 3 g or more per 24 h, ramipril safely reduced the rate...